FDA Adverse Event Malfunction Summary report: N

RELION INSULIN SYRINGES 1/2ML 31 GAUGE, 8MM (5/16") U-100 100COUNT

MDR report key: 14249994 · Received April 29, 2022

Report

Report Number
1920898-2022-00304
Event Type
Malfunction
Date Received
April 29, 2022
Date of Event
April 7, 2022
Report Date
April 29, 2022
Manufacturer
BD MEDICAL - DIABETES CARE
Product Code
FMF
UDI-DI
00681131311762
PMA / PMN Number
K190054
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OK, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

MEDICAL DEVICE EXPIRATION DATE: UNKNOWN. A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D9: DEVICE AVAILABLE FOR EVAL: YES. D9: RETURNED TO MANUFACTURER ON: 19-MAY-2022. H6: INVESTIGATION SUMMARY: CUSTOMER RETURNED (2) 0.5ML, 31 GAUGE, 8MM SYRINGES FROM LOT 9231071. THE FIRST SYRINGE HAD ITS NEEDLE SHIELD AND HUB SEPARATE FROM THE BARREL. THE HUB HAS BECOME LODGED INSIDE THE SHIELD. THERE IS NO DAMAGE TO EITHER THE CONNECTOR AT THE DISTAL TIP OF THE BARREL OR ITS RESPECTIVE NEEDLE HUB. NO SIGNS OF USE AND NO OTHER DEFECTS FOUND. THE REMAINING SYRINGE WAS RETURNED FULLY INTACT. A NEEDLE SHIELD PULL FORCE TEST WAS PERFORMED ON THE SYRINGE. THE NEEDLE SHIELD REQUIRED 2.53 LBS OF FORCE TO BE REMOVED. THE HUB REMAINED ATTACHED TO THE BARREL OF THE SYRINGE. THE SPECIFICATION STATES THAT ALL PULL FORCES WITHIN THE RANGE OF 0.85 LBS TO 5.95 LBS ARE ACCEPTABLE. WITH THE NEEDLE HUB ATTACHED AND THE NEEDLE SHIELD BEING WITHIN PULL FORCE SPECIFICATION, THE REPORT OF THE HUB SEPARATING FROM THE BARRELS COULD NOT BE CONFIRMED FOR THIS SAMPLE. A REVIEW OF THE DEVICE HISTORY RECORD WAS COMPLETED FOR BATCH# 9231071. ALL INSPECTIONS AND CHALLENGES WERE PERFORMED PER THE APPLICABLE OPERATIONS QC SPECIFICATIONS. THERE WERE ZERO (0) NOTIFICATIONS NOTED THAT PERTAINED TO THE COMPLAINT. BASED ON THE SAMPLES RECEIVED, EMBECTA WAS ABLE TO CONFIRM THE CUSTOMER¿S INDICATED FAILURE OF NEEDLE HUB SEPARATION IN 1 OF THE 2 SAMPLES. CAPA (B)(4) HAS BEEN OPENED TO ADDRESS THIS ISSUE.

Description of Event or Problem · 0

IT WAS REPORTED TWICE THAT WHILE USING A RELION INSULIN SYRINGES 1/2ML 31 GAUGE, 8MM (5/16") U-100 100 COUNT, THE HUB SEPARATED FROM THE SYRINGE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: STATED, NEEDLE HUB SEPARATED WHEN REMOVING NEEDLE SHIELD.

Description of Event or Problem · 0

IT WAS REPORTED TWICE THAT WHILE USING A RELION INSULIN SYRINGES 1/2ML 31 GAUGE, 8MM (5/16") U-100 100COUNT, THE HUB SEPARATED FROM THE SYRINGE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: STATED, NEEDLE HUB SEPARATED WHEN REMOVING NEEDLE SHIELD.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
104899 RELION INSULIN SYRINGES 1/2ML 31 GAUGE, 8MM (5/16") U-100 100COUNT PISTON SYRINGE FMF BD MEDICAL - DIABETES CARE 328509 9231071 00681131311762

Patients

Seq Age Sex Outcome Treatment
1 Unknown